glp 1 manufacturers The GLP-1 boom: Challenges, trends, and CapEx strategies for Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists

Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights

Reduced food intake means less dietary iron

speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences

GLP-1 receptors are expressed in several key regions implicated in addiction and reward processing, including the ventral tegmental area (VTA), nucleus accumbens, amygdala, hippocampus, and lateral hypothalamus

I think GLP-1 drugs are likely to follow a similar path